Hanugen Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -3.32%
- Profit Growth 22.90%
- Ebitda 107.34%
- Net Worth 43.45%
- Total Assets 202.37%
About Hanugen Therapeutics
Hanugen Therapeutics Private Limited (HTPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 February 2017 (Seven years and 11 months 11 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rav Anand, Arun Shastry, and Manjulam serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73200KA2017PTC100686
-
Company No.
100686
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Feb 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Hanugen Therapeutics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rav Anand
|
Director | 20-Feb-2017 | Current |
|
Arun Shastry
|
Director | 20-Feb-2017 | Current |
|
Manjulam
|
Director | 20-Feb-2017 | Current |
Financial Performance of Hanugen Therapeutics.
Hanugen Therapeutics Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 3.32% decrease. The company also saw a substantial improvement in profitability, with a 22.9% increase in profit. The company's net worth Soared by an impressive increase of 43.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hanugen Therapeutics?
In 2021, Hanugen Therapeutics had a promoter holding of 90.83% and a public holding of 9.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hanugen Therapeutics?
Unlock and access historical data on people associated with Hanugen Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hanugen Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hanugen Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.